“showed a trend”

toyonensis BCT-7112 T group showed a trend of greater values, for example, villus height per crypt depth of duodenum ( P = 0.16) and ileum ( P = 0.12) compared with those in the control group.

As to adverse effects, LT group showed a trend of more adverse events compared to ST group (HR =1.84, 95% CI: 0.79–4.29), but with no statistical difference (P=0.16).

Patients bearing K-ras mutations, showed a trend to a shorter PFS (p:0.051) and no differences in OS (p=0.16).

CNV signature 3 seemed to be associated with a non-statistical improved survival (HR = 0.51 [0.24; 1.04], adjusted p -value = 0.16), while CNV signature 6 showed a trend towards poorer OS (HR = 4.59 [0.9; 23.4], adjusted p -value = 0.16).

Even in the absence of visual input, posterior RSC showed a trend toward larger decoding errors as compared with the anterior subregion (13.4 ± 0.7 cm vs. 20.1 ± 3.8 cm; p = 0.16, anterior vs. posterior, n = 6 vs. 3 sessions; Supplementary Fig. 3B ).

Kaplan–Meier curves analyzing any one graft with > 50 graft stenosis and mortality showed a trend towards a decrease in the combined endpoint in TAR ( p = 0.16) ( Figure 1 ).

Results for the outcomes physical victimisation and psychological victimisation were similar to the results of any adult victimisation and showed a trend towards a negative interaction as well ( p = 0.16 for physical victimisation, p = 0.07 for psychological victimisation).

In agreement with this finding, in patients receiving full-dose of MMF at baseline (i.e., 2000 mg/day), complete drug withdrawal showed a trend towards reduced severe COVID-19 (41.7% vs. 69.2%, p = 0.16) [ 17 ].

The test for subgroup differences on overall POAF showed a trend (P = 0.16).

Kaplan–Meier survival analysis was then performed, and the CRC patients with organoid-forming tumors (n = 440) showed a trend towards worse overall survival than those with non-organoid-forming tumors (n = 68; p = 0.16, Figure 5 ). 3.

Discrimination improved modestly, with an increase in AUC from 0.74 to 0.78; this difference showed a trend toward statistical significance by DeLong’s test (ΔAUC 0.038; P = 0.16).

Among the conventionally high-risk patients as defined by age, stage, histology, and MYCN status ( n = 30) [ 23 , 24 ], PET-UHR ( n = 22) showed a trend of worse 5-year EFS (12% [2%–31%] vs . 38% [6%–72%]; P = 0.16) and OS (24% [6%–47%] vs . 50% [1%–91%]; P = 0.07).

The sera from asthmatic mice (collected on day 52) showed a trend toward higher levels of HDM-specific IgE than the sham mice ( p = 0.16), while showing significantly higher levels of HDM-specific IgG 1 ( p < 0.05) and IgG 2a ( p < 0.05) ( Figure 3 -f).

Treatment of B cells with iberdomide resulted in a significant reduction in the percentage of CD27 + IgD - B cells (iberdomide 8.6±13.9 vs vehicle 34.9±19.3, p=0.028), without reducing the percentage of IgD + CD20 low naïve B cells—if anything, treatment with iberdomide showed a trend towards an increase in the percentage of naïve B cells (iberdomide 45.6±19.9 vs vehicle 30.7±18.9, p=0.160) and led to a significant increase in double negative (DN) CD27 - IgD - B cells considered part of the class-switched memory compartment (iberdomide 45.89±16.7 vs vehicle 29.4±16.2, p=0.015) ( figure 2B, C ).

study [ 14 ] showed a trend toward a reduction in infectious morbidity (RR 0.83, 95 % CI 0.64–1.08, p =0.16; heterogeneity I 2 = 0 %).

No baseline characteristic identified responder patients; however, the confidence interval showed a trend that patients with FEV 1 <35% predicted were more likely to respond (relative risk 1.67 (95% CI 0.87–3.21) p=0.16).

1d ) and PKCε also showed a trend towards higher values (1.5 ± 1.5 vs 2.1 ± 1.9 AU, p = 0.16, CPM) at 2 weeks.

Complete MMF withdrawal during hospitalization showed a trend towards a reduced risk of progression to severe COVID-19 (41.7% vs 69.2%; P = 0.16)[ 53 ].

1 , and found that sEPSCs showed a trend towards higher frequency in the inhibitory neurons than in the excitatory neurons (Fig. 3c ; 1.32 ± 0.30 Hz (2 mM, Ext) vs. 3.08 ± 1.16 Hz (2 mM, Int); P = 0.16, unpaired t test).

The <1 year or >9 years group showed a trend toward improved OS (HR 0.43; 95% CI 0.13–1.42, p = 0.16) (Supplementary Fig. 3 ).

Consequently, the LV end-systolic and end-diastolic internal diameters showed a trend toward a decrease (p = 0.16 and p = 0.09, respectively), and the fractional shortening was significantly increased in the CKD-only group compared to the sham group (Table 1 ).

FA was significantly reduced in C3-C5 of patients (p < 0.001) and showed a trend to decrease in C1-C2 (p = 0.160) ( Fig. 4 A).

Treatment with TGFβ upregulated MMP1 secretion, and GTX-11m showed a trend to reduce it (IPF p = 0.160, sarcoidosis p = 0.309, HP p = 0.059, control p = 0.144) ( Figure 5C ).

Since the study of Katz et al used a higher dosage than the other included studies, after its exclusion, the pooling result showed a trend favouring daptomycin (five RCTs, 638 patients, OR=1.39, 95% CI 0.88 to 2.19, p=0.16, I 2 =0; figure 2 D).

Conversely, CRC patients with higher GAS1 expression showed a trend toward improved overall prognosis (Fig. 7F , 9-month PFS rates for high vs. low: 73.9 vs. 50.0%, p = 0.160).